Ding Xu | Emory University | Xulab-heparan | Atlanta
Ding Xu Lab at the Emory University, School of Medicine, studies Heparan sulfate and Heparan sulfate-binding proteins in bone and cartilage diseases.
Lab members | Xulab
Dr. Xu has been studying heparan sulfate his whole scientific career. He was highly fortunate to be mentored by two leading experts in heparan sulfate biology. With Dr. Jian Liu at UNC Chapel Hill, he studied biosynthetic enzymes of heparan sulfate and became an expert in HS structure, HS biosynthesis, protein expression and purification, and ...
Publications - Xulab
Yin Luo, Miaomiao Li and Ding Xu (2022). A disease-causing human osteoprotegerin mutant exists in hyper-oligomerized forms. Scientific Report . 2022 Sep 10;12(1):15279.
Therapeutics - xulab
Chihyean Ong, Miaomiao Li, Ding Xu (2023). Development of mAbs that block the heparan sulfate binding site of receptor for advance glycation end-product (RAGE). Glycobiology .
Inflammation - Xulab
Miaomiao Li, Chih Yean Ong, Christophe J Langouët-Astrié, Lisi Tan, Ashwni Verma, Yimu Yang, Xiaoxiao Zhang, Dhaval K. Shah, Eric P. Schmidt and Ding Xu (2022). Heparan Sulfate-dependent RAGE oligomerization is indispensable for pathophysiological functions of RAGE.
Lab photos | Xulab
Jun 26, 2024 · Xu Lab. Home. Lab members. Research. Bone remodeling; Inflammation; Therapeutics; Publications. Collaborators. News. Lab photos. More. Farewell party to Miaomiao, Yin, Chihyean and Buffalo (06-26-2024) Xiaoxiao's Farewell party (08-28-2021) bottom of page ...